Form 4 for EXEL EXELIXIS, INC.
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-15 · accession 0000939767-24-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $20.39 | -10.6K | 479.0K | -2% | -$216.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | F | D | 10,630 | $20.39 | 479,031 | D | — | — | (F1) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded January 5, 2023. (F2) Includes 270,181 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |